Cardiometabolic Traits, Sepsis, and Severe COVID-19: A Mendelian Randomization Investigation
- PMID: 32966752
- PMCID: PMC7594537
- DOI: 10.1161/CIRCULATIONAHA.120.050753
Cardiometabolic Traits, Sepsis, and Severe COVID-19: A Mendelian Randomization Investigation
Keywords: Mendelian randomization analysis; coronavirus; risk factors; sepsis.
Conflict of interest statement
Dr Moore has consulted for DNAelectronics (2015–2018), Dairy Crest (2017–2018), bioMerieux (2013–2020), Pfizer (2018–2020), and Umovis Laboratory (2020); received speaker fees from Profile Pharma (2018); received research grants from the National Institute for Health Research (2013–2020), CW+ Charity (2018–2019), and Leo Pharma (2016); and received educational grants from Eumedica (2016–2018). Dr Gill is employed part-time by Novo Nordisk. The other authors report no conflicts.
Figures
References
-
- Ponsford MJ, Gkatzionis A, Walker V, Grant A, Wootton RE, Moore LSP, Fatumo S, Mason A, Zuber V, Willer C, et al. Cardiometabolic traits, sepsis and severe covid-19 with respiratory failure: a Mendelian randomization investigation [published online June 20, 2020]. medRxiv. doi: 10.1101/2020.06.18.20134676. https://www.medrxiv.org/content/10.1101/2020.06.18.20134676v1. - DOI - PMC - PubMed
-
- Sattar N, McInnes IB, McMurray JJV. Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation. 2020;142:4–6. doi: 10.1161/CIRCULATIONAHA.120.047659 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
